Survival following surgical correction of congenital cardiovascular defects is unlikely if pulmonary hypertension cannot be decreased significantly. Infusions of acetylcholine decreased pulmonary vascular resistance in 6 of 11 patients having pulmonary hypertension associated with atrial or ventricular septal defects. When the acetyleholine was combined with the breathing of oxygen, resistance decreased further. These findings are consistent with the theory that, at some stage, the pulmonary hypertension in cases of congenital heart disease is maintained at least in part by vasoconstrietion and therefore is potentially reversible.
M ANY patients with pulmonary hypertension associated with intracardiac or great vessel defects have increased resistance to blood flow through the pulmonary vascular bed. [1] [2] [3] [4] [5] [6] It is important to know how much, if any, of this increased resistance is due to active vasoconstriction. If vasoconstriction can play an important role, then its assessment may be helpful in evaluating the condition of patients with pulmonary hypertension before surgical correction of the defects, and in understanding the way in which the constriction is induced and maintained. Acetylcholine, which causes local vasodilatation when injected intra-arterially into systemic vessels7 has been used recently in the study of the pulmonary circulation. [8] [9] [10] Rapid inactivation of this substance in the circulating blood makes possible its injection into the pulmonary artery in sufficient concentration to affect the pulmonary vessels without altering the hemodynamics of the This project was supported in part by a grant from the Minnesota Heart Association to Dr. Shepherd, and in part by grant no. H-3532, National Institutes of Health, U.S. Public Health Service. 381 systemic circulation. Harris8 found that sudden single injections of acetylcholine into the pulmonary artery of patients with pulmonary hypertension, some of whom had congenital heart disease, could produce a transient fall in the pulmonary artery pressure. He suggested that this fall resulted from a decrease in pulmonary vascular resistance.
We have extended the technic by the use of constant-rate infusions of acetylcholine in an attempt to obtain the data necessary to calculate the changes in pulmonary vascular resistance. These observations were made first with the patients breathing air and repeated with the patients breathing oxygen; the latter was done because oxygen breathing alone can lower pulmonary resistance. [11] [12] [13] The results show that the elevated pulmonary vascular resistance may be decreased during administration of acetyleholine, whether the patient is breathing air or oxygen. METHODS Eleven patients, aged 8 to 51 years, with pulniuonary hypertension were studied. Six had an In 3 cases in which the 7-F. catheter was too large for the vein, 2 5-F. catheters of Lehman type were used and inserted into the pulmonary artery. One was used for the injection and the other was connected via a 2-way stopcock to a strain-gage manometer and cuvette oximeter for monitoring pressure and oxygen saturation. In some patients the oxygen saturation of radial arterial blood was determined continuously during the infusion by a euvette oximeter.
The procedure was usually carried out first with the patient breathing air and then repeated with the patient breathing 99.6 per cent oxygen. No measurements were made until the patient had been breathing oxygen for at least 5 minutes. As a safety measure and in order to be certain that an effective concentration of acetyleholine reached the small pulmonary vessels, a dose-response curve was made for each patient. In patients who showed a significant fall in pulmonary artery pressure, or a rise in pulmonary artery oxygen content, or both, without systemic or respiratory effects, no attempt was made to increase the dose to a point where changes in heart rate, systemic blood pressure, tidal volume, or respiratory rate were produced. If no effect was observed on the pulmonary circulation, the dose was increased until slight systemic effects were noted. The usual dose of acetyleholine chloride was 2 to 4 mg. per minute dissolved in isotonic saline solution, but in 1 patient 24 mg. was given per minute. The volume infused did not exceed 24 ml. per minute.
The total pulmonary resistance, expressed in dynes second em. 5 decreases in pulmonary resistance on administration of acetylcholine. If the pulmonary resistance when the patient is breathing air is taken as 100 per cent, the pulmonary resistance in the 5 patients for whom a complete set of data was obtained decreased 23 per cent with infusion of acetyleholine alone, 29 per cent on breathing oxygen, and 43 per cent oil breathing oxygen and receiving acetyleholine.
Pulmonary Hypertension Associated with Ventricular Septal Defect. The most dramatic response to acetylcholine that was obtained in any of the patients studied is illustrated by figure 3. The patient, an 8-year-old boy (case 7), had a ventricular septal defect. The pressures ill the pulmonary artery and femoral artery of this patient were similar at the start of the procedure. Onl infusion of acetylcholine while the patient was breathing air, the pulmonary artery pressure fell to less than half its previous value and the oxygen saturation in the pulmonary artery blood rose from 75 to 83. The calculated pulinonary resistance fell from 1620 to 510 dynes see. em.-5 Breathing oxygen had only a minimal effect with a change in resistance from 1620 to 1250 dynes see. em.-5 The high resistance to flow through the pulmonary vessels in this boy permitted the equalization of pressures in the 2 ventricles. When this resistance had been markedly decreased by the acetyleholine, a large pressure gradient developed between the ventricles, and the defect itself now constituted a major part of the resistance limiting the arteriovenous shunt. This patient also ( fig. 3) showed a slight but definite decrease in systemic arterial oxygen saturation similar to that shown in figure 2. Acetyleholine had little effect in reducing the pulmonary resistance in a 43-year-old woman (ease 9 acetyleholine in a patient with a large ventricular septal defect, the evidence for a drop in resistance may be missed as it would consist chiefly of a change in oxygen content of pulmonary artery blood since systolic pressures in the 2 sides of the heart would be equalized via the large defect. The fact that the oxygen saturation of systemic arterial blood does not change may well be the resultant of a decrease in pulmonary vein oxygen saturation offset by a diminution in a venoarterial shunt. Similarly, in a patient with an atrial septal defect a decrease in pulmonary vascular resistance could be missed if the increased flow through the pulmonary vessels consequent to the infusion of acetylcholiiue mnaitutained the pressure in the pulmonary artery at its previous level, the principal change being a rise in oxygen content in the pulmonary artery blood.
One additional problem in interpretation merits emphasis. Acetylcholine is a potent bronchoeonstrictor, and we have found that doses of acetylcholine which cause bronchoconstriction actually can increase a venoarterial shunt as measured by indicator-dilution curves. It is important, therefore, to monitor the pattern of respiration during infusion. Indeed, such bronchoconstriction might explain the rise in pulmonary artery pressure reported in anesthetized dogs27 and ill newborn infants.28
It is difficult to state the magnitude of change in calculated pulmonary resistance that should be accepted as demonstrating an increase in caliber of the pulmonary vessels. If the pulmonary resistance when the patients were breathing air is taken as 100 per cent, a fall in resistance of more than 45 per cent occurred in 4 patients with an atrial and in 2 with a ventricular septal defect when they were receiving acetylcholine, either when they were breathing air or oxygen.
We believe that a fall of this magnitude represents a dilatation of vessels in the lung.
In the dosages used, neither inhalation of oxygen nor the infusion of acetylcholine produces a maximal reduction of pulmonary vascular resistance. Indeed, one agent mnay SHEPHERD, SEMLER, IIEI1MHOLiZ, WOOD be effective and the other ineffective in any given case.
Our results indicate that active vasoconstriction is important in maintaining the increased pulmonary resistance in many patients with congenital heart disease. This constriction is present both in patients with ventricular septal defects in whom the smooth muscle in the pulmonary vessels may have persisted from birth and in patients with atrial septal defect in whom it is likely that the muscle which had regressed since birth has developed again. 29 Vasomotor tone now has been demonstrated in the pulmonary vessels of normal man,10, 30 in patients with mitral stenosis associated with pulmonary hypertension,9 31 cor pulmonale,20 and in idiopathic pulmonary hypertension.20 SUMMARY Acetylcholine was administered by constant-rate infusion into the pulmonary arteries of 11 patients having pulmonary hypertension associated with atrial or ventricular septal defect.
The oxygen consumption, oxygen saturation in the pulmonary artery and systemic arterial blood, and the pulmonary artery pressure were recorded continuously before, during, and after the infusion. These data were used to determine changes in total pulmonary resistance during infusion of acetylcholine.
All 6 of the patients with atrial septal defects showed some decrease in resistance when receiving acetylcholine. If the pulmonary resistance when the patient was breathing air is taken as 100 per cent, the decrease was 23 (range 15 One patient with both an atrial and a ventricular septal defect showed no response.
As there was no evidence of a decrease in left atrial pressure with acetylcholine, these changes in total pulmonary resistance demonstrated by the method employed presumably represent an actual reduction in pulmonary vascular resistance.
It is concluded that active constriction of pulmonary vessels can be an important factor in maintaining the high resistance to pulmonary blood flow found in some patients with congenital heart disease. Le 6 patientes con defectos atrio-septal monstrava omnes un certe mesura de reduc-tion del resistentia durante le infusion de acetylcholina. In comparation conl le resistentia pulmonar durante le respiration de sere in le absentia de acetylcholina, le reduction amontava a un valor medie de 23 pro cento (minimo-maximo: 15 a 51) con le infusion de acetylcholina e le respiration de aere, de 29 pro cento (minimo-maximo: 9 a 33) con le respiration de oxygeno sin infusion de acetylcholina, e de 43 pro cento (minimo-maximo: 27 a 60) con le infusion de acetylcholina e le respiration de oxygeno.
Inter le 4 patientes con solmente defectos ventriculo-septal, un respondeva a ni oxygeno ni acetylcholina. Inter le alteres, le procentage medie del reduction del resistentia con infusion de acetylcholina e respiration de aere esseva 31 (minimo-maximo: 10 a 69), con respiration de oxygeno e sin infusion de acetylcholina 33 (minimo-maximo: 25 a 66), e conl respiration de oxygeno e infusion de acetylcholina 57 (minimo-maximo: 35 a 74).
UI1 patiente con defecto atrio-septal e defeeto ventriculo-septal monstrava nulle responsa.
Viste que nihil indicava le occurrentia de un reduction del tension sinistro-atrial como effecto del acetylcholina, le alterationes del total resistentia pulmonar demonstrate per le methodo empleate representa probibilemente un genuin reduction del resistentia pulmono-vascular.
Es concludite que le constriction active del vasos pulmonar pote esser un factor importante in mantener le alte resistentia al fluxo pulmonar de sanguine que es notate in certe patientes con congenite morbo cardiac.
